MiMedx Group, Inc.
MiMedx Group, Inc. (MDXG) Revenue
Annual & quarterly revenue history · segment & region breakdown
MDXG · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMiMedx Group, Inc. trailing twelve-month (TTM) revenue is $0.39B, an increase of 19.99% year-over-year from $0.42B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.42B | +$0.07B | +19.99% |
| 2024-12-31 | $0.35B | +$0.03B | +8.52% |
| 2023-12-31 | $0.32B | +$0.05B | +20.03% |
| 2022-12-31 | $0.27B | +$0.03B | +10.67% |
| 2021-12-31 | $0.24B | -$0.01B | -2.50% |
| 2020-12-31 | $0.25B | -$0.05B | -17.05% |
| 2019-12-31 | $0.30B | -$0.06B | -16.67% |
| 2018-12-31 | $0.36B | +$0.04B | +11.82% |
| 2017-12-31 | $0.32B | +$0.08B | +31.07% |
| 2016-12-31 | $0.25B | +$0.06B | +30.82% |
Compare revenue vs peers
BiotechnologyCompare MDXG revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income MiMedx Group, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
MiMedx Group, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from MiMedx Group, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MDXG revenue · 4 questionsMDXG's trailing twelve-month (TTM) revenue is $0.39B. That is an increase of 19.99% year-over-year from $0.42B in FY2025.
▸ Source: FMP · MiMedx Group, Inc. SEC filings · GAAP · MiMedx Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026